Infectious disease doctors ask government to explain how it decides who gets Gilead’s remdesivir
May 07, 2020 at 14:31 PM EDT
Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug.
